Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score: is the patient suitable for Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS)?
Capobianco, Ivan Oldhafer, Karl J Fard-Aghaie, Mohammed-Hossein Robles-Campos, Ricardo Brusadin, Roberto Petrowsky, Henrik Linecker, Michael Mehrabi, Arianeb Hoffmann, Katrin Li, Jun
Capobianco, Ivan
Oldhafer, Karl J
Fard-Aghaie, Mohammed-Hossein
Robles-Campos, Ricardo
Brusadin, Roberto
Petrowsky, Henrik
Linecker, Michael
Mehrabi, Arianeb
Hoffmann, Katrin
Li, Jun
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2022-02
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Background: Preoperative patient selection in Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS) is not always reliable with currently available scores, particularly in patients with primary liver tumor. This study aims to (I) to determine whether comorbidities and patients characteristics are a risk factor in ALPPS and (II) to create a score predicting 90-day mortality preoperatively.
Methods: Thirteen high-volume centers participated in this retrospective multicentric study. A risk analysis based on patient characteristics, underlying disease and procedure type was performed to identify risk factors and model the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score. A nonparametric receiver operating characteristic analysis was performed to estimate the predictive ability of our score against the Charlson Comorbidity Index (CCI), the age-adjusted CCI (aCCI), the ALPPS risk score before Stage 1 (ALPPS-RS1) and Stage 2 (ALPPS-RS2). The model was internally validated applying bootstrapping.
Results: A total of 451 patients were included. Mortality was 14.4%. The CAPRA score is calculated based on the following formula: (0.1 × age) - (2 × BSA) + 1 (in the presence of primary liver tumor) + 1 (in the presence of severe cardiovascular disease) + 2 (in the presence of moderate or severe diabetes) + 2 (in the presence of renal disease) + 2 (if classic ALPPS is planned). The predictive ability was 0.837 for the CAPRA score, 0.443 for CCI, 0.519 for aCCI, 0.693 for ALPPS-RS1 and 0.807 for ALPPS-RS2. After 1,000 cycles of bootstrapping the C statistic was 0.793. The accuracy plot revealed a cut-off for optimal prediction of postoperative mortality of 4.70.
Conclusions: Comorbidities play an important role in ALPPS and should be carefully considered when planning the procedure. By assessing the patient's preoperative condition in relation to ALPPS, the CAPRA score has a very good ability to predict postoperative mortality.
Citation
Capobianco I, Oldhafer KJ, Fard-Aghaie MH, Robles-Campos R, Brusadin R, Petrowsky H, Linecker M, Mehrabi A, Hoffmann K, Li J, Heumann A, Hernandez-Alejandro R, Tun-Abraham ME, Jovine E, Serenari M, Bjornsson B, Sandström P, Alikhanov R, Efanov M, Muiesan P, Schlegel A, van Gulik TM, Olthof PB, Stavrou GA, Serna-Higuita LM, Königsrainer A, Nadalin S. Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score: is the patient suitable for Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS)? Hepatobiliary Surg Nutr. 2022 Feb;11(1):52-66. doi: 10.21037/hbsn-21-396
Type
Article